| Drug Name | Erlotinib |
|---|---|
| Other Drug Names | CP-358774; CP-358774-01; Erlotinib hydrochloride; NSC-718781; OSI-774; R-1415; RG-1415; RO-508231; Ro50-8231; Tarceva |
| Chemical Name | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine |
| Formula | C22H23N3O4 |
| Mol. Wt. | 393.44 |
| CAS No. | 183321-74-6 |
| UNII | J4T82NDH7E |
| Target-based Actions | Epidermal growth factor receptor(EGFR) inhibitor |
| ATC Codes | L01XE03 |
| Highest Status | 2004年11月由FDA批准上市 |
| Originator Company | OSI Pharmaceuticals |
| Structure |
 |